Biotech news
Biotech
UK governmental agency Public Health England has entered into a research and development partnership with UK-based pharmaceutical company Enesi Pharma. 3 October 2018
Americas
Dykema has strengthened its Minneapolis, Minnesota office with the addition of two lawyers from Moore & Hansen as senior counsel. 2 October 2018
Pharma
Crowell & Moring has welcomed Gunther Meyer, who previously led the Brussels IP group at Eversheds Sutherland, as a senior counsel in the firm’s IP group. 2 October 2018
Asia
Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China. 1 October 2018
Americas
Teva has once again taken Eli Lilly to court over a migraine drug, just hours after Eli Lilly’s gained Food and Drug Administration approval to market Emgality. 1 October 2018
Americas
US-based Alexion Pharmaceuticals has announced its plan to acquire Syntimmune, a clinical-stage biotechnology company. 1 October 2018
Americas
While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out. 27 September 2018
Biotech
Big data presents an array of opportunities for the pharmaceutical industry, but companies must be careful who they partner with, said Myra McCormack, associate patent counsel at Johnson & Johnson, yesterday. 26 September 2018
Americas
The inter partes review process has had a huge impact on biosimilar litigation, but it isn’t truly fulfilling its goal of being an alternative to district court litigation. 26 September 2018
Americas
DLA Piper has added two partners from Hogan Lovells to its IP and technology practice in New York. 25 September 2018